Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate Tablet and Emtricitabine/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2016
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Tenofovir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms VOICE
- 10 Jun 2017 Biomarkers information updated
- 06 Mar 2014 Adherence results (n=472) presented at the 21st Conference on Retroviruses and Opportunistic Infections.
- 16 Oct 2013 Substudy has been completed, according to the ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History